Welcome to kongre.net
Speaker
Vice President, Research & Head, Protein Therapeutics, Amgen
Suzanne Edavettal, Vice President, Research & Head, Protein Therapeutics at Amgen, spoke at 17th World ADC San Diego (San Diego, United States of America, 12–15 Oct 2026) in the session “Panel Discussion: Contextualizing the Current Status of Novel ADC Design & Development to Ensure Future ADC Success & Differentiated Patient Impact”.
12–15 Oct 2026San Diego, United States of America
Associate Director, Medicinal Chemistry, AstraZeneca
Senior Director, Chemistry, Sutro Biopharma
Chief Scientific Officer, Callio Therapeutics
President & Founder, Bramhill Biologics Consulting
Executive Director, Product Stewardship Lead, AstraZeneca
Senior Director - Bioconjugation Chemistry, Abzena
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Suzanne Edavettal, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].